Giulia C. Kennedy - 07 Sep 2021 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role: Chief Scientific & Med Officer
Signature: /s/ Jane Alley as attorney-in-fact
Issuer symbol: VCYT
Transactions as of: 07 Sep 2021
Net transactions value: -$470,045
Form type: 4
Filing time: 09 Sep 2021, 17:07:35 UTC
Previous filing: 07 Sep 2021
Next filing: 03 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCYT	Common Stock	Options Exercise	$26,348	+4,406	+8.6%	$5.98	55,381	07 Sep 2021	Direct	F1
transaction	VCYT	Common Stock	Options Exercise	$75,788	+3,750	+6.8%	$20.21	59,131	07 Sep 2021	Direct	F1
transaction	VCYT	Common Stock	Options Exercise	$108,019	+4,375	+7.4%	$24.69	63,506	07 Sep 2021	Direct	F1
transaction	VCYT	Common Stock	Sale	$607,946	-12,034	-19%	$50.52	51,472	07 Sep 2021	Direct	F1, F2
transaction	VCYT	Common Stock	Sale	$25,463	-497	-0.97%	$51.23	50,975	07 Sep 2021	Direct	F1, F3
transaction	VCYT	Common Stock	Sale	$46,791	-926	-1.8%	$50.53	50,049	08 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCYT	Stock Option (right to buy)	Options Exercise	$0	-4,406	-33%	$0.000000	8,813	07 Sep 2021	Common Stock	4,406	$5.98	Direct	F1, F4
transaction	VCYT	Stock Option (right to buy)	Options Exercise	$0	-3,750	-14%	$0.000000	22,500	07 Sep 2021	Common Stock	3,750	$20.21	Direct	F1, F5
transaction	VCYT	Stock Option (right to buy)	Options Exercise	$0	-4,375	-9.1%	$0.000000	43,750	07 Sep 2021	Common Stock	4,375	$24.69	Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
F2	Represents weighted average sales price. Sale prices for the transactions range from $50.06 to $51.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F3	Represents weighted average sales price. Sale prices for the transactions range from $51.07 to $51.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4	The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F5	The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F6	The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.